Literature DB >> 2522557

Genetic dissection of the transactivating domain of the E1a 289R protein of adenovirus type 2.

M L Fahnestock1, J B Lewis.   

Abstract

A series of linker-scanning, deletion, and frameshift mutations were made in the pm975 variant of the adenovirus type 2 E1a gene, which expresses only the larger of the two major E1a proteins. Most of these were within the 46-amino-acid segment unique to the larger E1a protein product (the 289R protein), which confers on it the ability to activate in trans the expression of other genes. The mutations were recombined into virus and assayed by in vitro transcription in nuclei isolated from infected cells for their ability to activate the transcription of other viral early genes and of the endogenous hsp70 gene. Mutant E1a proteins from which the 289R-unique segment was removed by deletion or truncation did not completely lose the ability to transactivate by comparison with a virus which makes no E1a at all, indicating that sequences outside this domain are active in the positive regulation of transcription. The E1a mutations tested fell into several classes: those that increased transactivation of virtually all genes, those that severely depressed transactivation of all genes, and those that depressed transactivation only moderately. Each mutation had similar effects on the expression of all transcription units tested, indicating a common process in their transactivation. However, some mutants in the third category decreased transactivation of some induced genes more severely than of others. Such gene-specific defects suggest the existence of subclasses of E1a-responsive transcription units, consistent with the involvement of diverse proteins in the transactivation of different genes. Two specific structural components of the transactivating domain, a putative metal-binding element and a region with high potential for beta-sheet formation at its carboxy-terminus, appear to be important to the transactivation function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522557      PMCID: PMC248381     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

2.  Functions of adenovirus E1A.

Authors:  A J Berk
Journal:  Cancer Surv       Date:  1986

Review 3.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.

Authors:  T Harrison; F Graham; J Williams
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

5.  Transcriptional control signals of a eukaryotic protein-coding gene.

Authors:  S L McKnight; R Kingsbury
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

6.  Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells.

Authors:  T Shenk; N Jones; W Colby; D Fowlkes
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

7.  Low molecular weight viral RNAs transcribed by RNA polymerase III during adenovirus 2 infection.

Authors:  R Weinmann; T G Brendler; H J Raskas; R G Roeder
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

8.  Control of adenovirus early gene expression: a class of immediate early products.

Authors:  J B Lewis; M B Mathews
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

9.  Adenovirus type 2 early proteins synthesized in vitro and in vivo: identification in infected cells of the 38,000- to 50,000- molecular-weight protein encoded by the left end of the adenovirus type 2 genome.

Authors:  M L Harter; J B Lewis
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

10.  Structure of two adenovirus type 12 transforming polypeptides and their evolutionary implications.

Authors:  M Perricaudet; J M le Moullec; P Tiollais; U Pettersson
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

View more
  9 in total

1.  Limited temperature-sensitive transactivation by mutant adenovirus type 2 E1a proteins.

Authors:  M L Fahnestock; J B Lewis
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

Review 2.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

Review 3.  Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Authors:  Peter Pelka; Jailal N G Ablack; Gregory J Fonseca; Ahmed F Yousef; Joe S Mymryk
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

4.  Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.

Authors:  J L Cook; C K Krantz; B A Routes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site.

Authors:  G F Morris; M B Mathews
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 6.  Adenovirus-E1A proteins transform cells by sequestering regulatory proteins.

Authors:  D S Peeper; A Zantema
Journal:  Mol Biol Rep       Date:  1993-04       Impact factor: 2.316

7.  Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a.

Authors:  R Kaddurah-Daouk; J W Lillie; G H Daouk; M R Green; R Kingston; P Schimmel
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

8.  The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation.

Authors:  M Bondesson; C Svensson; S Linder; G Akusjärvi
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

Review 9.  Hacking the Cell: Network Intrusion and Exploitation by Adenovirus E1A.

Authors:  Cason R King; Ali Zhang; Tanner M Tessier; Steven F Gameiro; Joe S Mymryk
Journal:  MBio       Date:  2018-05-01       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.